{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:29:11Z","timestamp":1784604551549,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.7759\/cureus.18425","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T16:47:13Z","timestamp":1633106833000},"source":"Crossref","is-referenced-by-count":3,"title":["Chemodenervation for Oromandibular Dystonia Utilizing Botulinum Toxins"],"prefix":"10.7759","author":[{"given":"Muhammad Atif","family":"Ameer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2005.07.007","article-title":"A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia","volume":"12","author":"Singer C","year":"2006","unstructured":"Singer C, Papapetropoulos S. A comparison of jaw-closing and jaw-opening idiopathic oromandibular dystonia. Parkinsonism Relat Disord. 2006, 12:115-8. 10.1016\/j.parkreldis.2005.07.007","journal-title":"Parkinsonism Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2009.04.006","article-title":"Meige syndrome: what's in a name?","volume":"15","author":"LeDoux MS","year":"2009","unstructured":"LeDoux MS. Meige syndrome: what's in a name?. Parkinsonism Relat Disord. 2009, 15:483-9. 10.1016\/j.parkreldis.2009.04.006","journal-title":"Parkinsonism Relat Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3514393","article-title":"Management of oromandibular dystonia: a case report and literature update","volume":"2017","author":"Gn S","year":"2017","unstructured":"Gn S, Nag A. Management of oromandibular dystonia: a case report and literature update. Case Rep Dent. 2017, 2017:3514393. 10.1155\/2017\/3514393","journal-title":"Case Rep Dent"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870030302","article-title":"Epidemiology of focal and generalized dystonia in Rochester, Minnesota","volume":"3","author":"Nutt JG","year":"1988","unstructured":"Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ 3rd. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988, 3:188-94. 10.1002\/mds.870030302","journal-title":"Mov Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7916\/D8TH8JSM","article-title":"Clinical, etiological, and therapeutic features of jaw-opening and jaw-closing oromandibular dystonias: a decade of experience at a single treatment center","volume":"4","author":"Gonzalez-Alegre P","year":"2014","unstructured":"Gonzalez-Alegre P, Schneider RL, Hoffman H. Clinical, etiological, and therapeutic features of jaw-opening and jaw-closing oromandibular dystonias: a decade of experience at a single treatment center. Tremor Other Hyperkinet Mov (N Y). 2014, 4:231. 10.7916\/D8TH8JSM","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.2.358","article-title":"Long-term effects of tetrabenazine in hyperkinetic movement disorders","volume":"48","author":"Jankovic J","year":"1997","unstructured":"Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997, 48:358-62. 10.1212\/wnl.48.2.358","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2020.100059","article-title":"Alarming levels of stigma toward generalized dystonia: a cross-cultural comparison","volume":"3","author":"Gharzai L","year":"2020","unstructured":"Gharzai L, Harney J, Higgins S, et al.. Alarming levels of stigma toward generalized dystonia: a cross-cultural comparison. Clin Park Relat Disord. 2020, 3:100059. 10.1016\/j.prdoa.2020.100059","journal-title":"Clin Park Relat Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10050208","article-title":"The expanding therapeutic utility of botulinum neurotoxins","volume":"10","author":"Fonfria E","year":"2018","unstructured":"Fonfria E, Maignel J, Lezmi S, et al.. The expanding therapeutic utility of botulinum neurotoxins. Toxins (Basel). 2018, 10:208. 10.3390\/toxins10050208","journal-title":"Toxins (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/toxins5020249","article-title":"Long-term efficacy and safety of botulinum toxin injections in dystonia","volume":"5","author":"Ramirez-Castaneda J","year":"2013","unstructured":"Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel). 2013, 5:249-66. 10.3390\/toxins5020249","journal-title":"Toxins (Basel)"},{"key":"ref10","article-title":"Etiology, diagnosis and management of oromandibular dystonia: an update for stomatologists","volume":"18","author":"Raoofi S","year":"2017","unstructured":"Raoofi S, Khorshidi H, Najafi M. Etiology, diagnosis and management of oromandibular dystonia: an update for stomatologists. J Dent (Shiraz). 2017, 18:73-81.","journal-title":"J Dent (Shiraz)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.35845\/kmuj.2020.20478","article-title":"Chemodenervation for cervical dystonia: a clinical review","volume":"12","author":"Ameer MA","year":"2020","unstructured":"Ameer MA, Bhatti D. Chemodenervation for cervical dystonia: a clinical review. Khyber Med Univ J. 2020, 12:253-8. 10.35845\/kmuj.2020.20478","journal-title":"Khyber Med Univ J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0975-5950.79218","article-title":"Oro-mandibular dystonia","volume":"1","author":"Gandhi YR","year":"2010","unstructured":"Gandhi YR. Oro-mandibular dystonia. Natl J Maxillofac Surg. 2010, 1:150-2. 10.4103\/0975-5950.79218","journal-title":"Natl J Maxillofac Surg"},{"key":"ref13","article-title":"Meiges Syndrome: an unusual cause of involuntary facial movements - two cases with literature review","volume":"2","author":"Reddy S","year":"2015","unstructured":"Reddy S, Padanad G. Meiges Syndrome: an unusual cause of involuntary facial movements - two cases with literature review. Natl J Maxillofac Surg. 2015, 2:1291-3.","journal-title":"Natl J Maxillofac Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2012.38.6.379","article-title":"Oromandibular dystonia after dental treatments: a report of two cases","volume":"38","author":"Jang SM","year":"2012","unstructured":"Jang SM, Cho YC, Sung IY, Kim SY, Son JH. Oromandibular dystonia after dental treatments: a report of two cases. J Korean Assoc Oral Maxillofac Surg. 2012, 38:379-83. 10.5125\/jkaoms.2012.38.6.379","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2012.12.004","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders","volume":"67","author":"Hallett M","year":"2013","unstructured":"Hallett M, Albanese A, Dressler D, Segal KR, Simpson DM, Truong D, Jankovic J. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon. 2013, 67:94-114. 10.1016\/j.toxicon.2012.12.004","journal-title":"Toxicon"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/000348948909800202","article-title":"Botulinum toxin injection for the treatment of oromandibular dystonia","volume":"98","author":"Blitzer A","year":"1989","unstructured":"Blitzer A, Brin MF, Greene PE, Fahn S. Botulinum toxin injection for the treatment of oromandibular dystonia. Ann Otol Rhinol Laryngol. 1989, 98:93-7. 10.1177\/000348948909800202","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.9.2102","article-title":"Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up","volume":"53","author":"Tan EK","year":"1999","unstructured":"Tan EK, Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999, 53:2102-7. 10.1212\/wnl.53.9.2102","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2010.04.007","article-title":"Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy","volume":"16","author":"Esper CD","year":"2010","unstructured":"Esper CD, Freeman A, Factor SA. Lingual protrusion dystonia: frequency, etiology and botulinum toxin therapy. Parkinsonism Relat Disord. 2010, 16:438-41. 10.1016\/j.parkreldis.2010.04.007","journal-title":"Parkinsonism Relat Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2003000400015","article-title":"[Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A]","volume":"61","author":"Cardoso F","year":"2003","unstructured":"Cardoso F. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A]. Arq Neuropsiquiatr. 2003, 61:607-10. 10.1590\/s0004-282x2003000400015","journal-title":"Arq Neuropsiquiatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2008.12.008","article-title":"Treatment of focal dystonias with botulinum neurotoxin","volume":"54","author":"Hallett M","year":"2009","unstructured":"Hallett M, Benecke R, Blitzer A, Comella CL. Treatment of focal dystonias with botulinum neurotoxin. Toxicon. 2009, 54:628-33. 10.1016\/j.toxicon.2008.12.008","journal-title":"Toxicon"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01441.x","article-title":"Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations","volume":"13 Suppl 1","author":"Bhidayasiri R","year":"2006","unstructured":"Bhidayasiri R, Cardoso F, Truong DD. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations. Eur J Neurol. 2006, 13 Suppl 1:21-9. 10.1111\/j.1468-1331.2006.01441.x","journal-title":"Eur J Neurol"},{"key":"ref22","article-title":"The forebrain or prosencephalon","author":"Gray H","year":"1918","unstructured":"Gray H. The forebrain or prosencephalon. Anatomy of the human body. Gray H (ed): Lea & Febiger, Philadelphia, PA; 1918."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-04583-4.00006-0","article-title":"Management of muscle injury and myofascial pain syndromes","author":"Gatterman MI","year":"2012","unstructured":"Gatterman MI, McDowell BL. Management of muscle injury and myofascial pain syndromes. Whiplash: A Patient Centered Approach to Management. Gatterman M (ed): Mosby, Maryland Heights, MO; 2012. 85-118. 10.1016\/B978-0-323-04583-4.00006-0"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-9602(03)80110-3","article-title":"The human digastric muscle: patterns and variations with clinical and surgical correlations","volume":"185","author":"De-Ary-Pires B","year":"2003","unstructured":"De-Ary-Pires B, Ary-Pires R, Pires-Neto MA. The human digastric muscle: patterns and variations with clinical and surgical correlations. Ann Anat. 2003, 185:471-9. 10.1016\/S0940-9602(03)80110-3","journal-title":"Ann Anat"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5125\/jkaoms.2013.39.4.188","article-title":"Correction of post-traumatic anterior open bite by injection of botulinum toxin type A into the anterior belly of the digastric muscle: case report","volume":"39","author":"Seok H","year":"2013","unstructured":"Seok H, Park YT, Kim SG, Park YW. Correction of post-traumatic anterior open bite by injection of botulinum toxin type A into the anterior belly of the digastric muscle: case report. J Korean Assoc Oral Maxillofac Surg. 2013, 39:188-92. 10.5125\/jkaoms.2013.39.4.188","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2174\/157488606777934431","article-title":"The possible adverse effects of intramuscular botulinum toxin injections and their management","volume":"1","author":"Bakheit AM","year":"2006","unstructured":"Bakheit AM. The possible adverse effects of intramuscular botulinum toxin injections and their management. Curr Drug Saf. 2006, 1:271-9. 10.2174\/157488606777934431","journal-title":"Curr Drug Saf"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.8.633","article-title":"Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm","volume":"53","author":"Jankovic J","year":"1990","unstructured":"Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990, 53:633-9. 10.1136\/jnnp.53.8.633","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref28","article-title":"Chemo-denervation of oromandibular dystonia with botulinum toxins: five-year experience (2794)","volume":"2794","author":"Ameer MA","year":"2020","unstructured":"Ameer MA, Syed N, Bertoni J, Hellman A, Torres-Russotto D, Bhatti D. Chemo-denervation of oromandibular dystonia with botulinum toxins: five-year experience (2794). Neurology. 2020, 2794:2794.","journal-title":"Neurology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/014556131109000210","article-title":"Jaw-opening dystonia: quality of life after botulinum toxin injections","volume":"90","author":"Charous SJ","year":"2011","unstructured":"Charous SJ, Comella CL, Fan W. Jaw-opening dystonia: quality of life after botulinum toxin injections. Ear Nose Throat J. 2011, 90:E9. 10.1177\/014556131109000210","journal-title":"Ear Nose Throat J"},{"key":"ref30","article-title":"Treatment of oromandibular dystonia using botulinum toxin injections - case series and illustrative muscle targeting","volume":"13","author":"Yu GL","year":"2018","unstructured":"Yu GL, Rosales RL. Treatment of oromandibular dystonia using botulinum toxin injections - case series and illustrative muscle targeting. Basal Ganglia. 2018, 13:7-16.","journal-title":"Basal Ganglia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66526-chemodenervation-for-oromandibular-dystonia-utilizing-botulinum-toxins","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:23Z","timestamp":1707507263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66526-chemodenervation-for-oromandibular-dystonia-utilizing-botulinum-toxins"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.18425","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}